Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Researchers compared OPC-34712 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In Kanto RegionCelecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in First-Episode and Drug-naive Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In Beijing
A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magentic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia and Related Disorders
This study has finished and is no longer accepting participants.
In MelbourneA Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BellflowerResearchers compared Paliperidone ER and placebo to find out how the approaches affected psychotic symptoms in young people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosResearchers are studying Aripiprazole to find out how it affects psychotic symptoms in people with schizophrenia.
This study ended early.
Location not clearly listedA Prospective Study of the Clinical Outcome Following Treatment Discontinuation After Remission in First-Episode Schizophrenia
This study has finished and is no longer accepting participants.
In BellvilleA Four-week, Multicentre, Double-blinded, Randomised, Active- and Placebo- Controlled, Parallel-group Trial Investigating Efficacy and Safety of Cannabidiol in Acute, Early-stage Schizophrenic Patients
This study ended early.
Multiple locations, including Glostrup MunicipalityAn Open Extension Study to Phase IIb Study of Clozapine in Patients With Treatment-resistant Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedAn Open Label, Long Term Trial of Risperidone Long Acting Microspheres in the Treatment of Patients Diagnosed With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers studied ALKS 3831, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers compared ALKS 9072, Low and ALKS 9072, High, tracking side effects to assess long-term safety in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.